View in EDS

Gemcitabine-Based Chemoradiotherapy Gets Improved with PARP Inhibitor in Pancreatic Cancer Cells.

Saved in:
Bibliographic Details
Title: Gemcitabine-Based Chemoradiotherapy Gets Improved with PARP Inhibitor in Pancreatic Cancer Cells.
Authors: Waissi, W.1, Burckel, H.1, Nicol, A.1, Larderet, G.1, Noel, G.1
Source: International Journal of Radiation Oncology, Biology, Physics. Nov2018 Supplement, Vol. 102, pe160-e160. 1p.
Database: Engineering Source
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2018.07.616